Showing results (31-40 of 113) with videos related to
Sort By:
Pageof 12
Clinical Pharmacology and Therapeutics|February 1, 1976
Phenytoin: pharmacokinetics and bioavailabilityR Gugler, C V Manion, D L AzarnoffPharmacology|January 1, 1979
Relationship between surface activity and toxicity to Chang liver cultures of tricyclic antidepressantsH Yasuhara, C A Dujovne, I UedaClinical Pharmacokinetics|May 1, 1983
Induction of salicyluric acid formation in rheumatoid arthritis patients treated with salicylatesR O Day, D D Shen, D L AzarnoffPediatric Research|February 1, 1975
Placental transfer and fetal urinary excretion of gentamicin during constant rate maternal infusionR E Kauffman, J A Morris, D L AzarnoffJournal of Pharmaceutical Sciences|March 1, 1975
Intersubject variation in absorption of digoxin in normal volunteersD H Huffman, C V Manion, D L AzarnoffClinical Pharmacology and Therapeutics|May 1, 1978
Kinetics, salivary excretion of amphetamine isomers, and effect of urinary pHS H Wan, S B Matin, D L AzarnoffResearch Communications in Chemical Pathology and Pharmacology|February 1, 1975
Separation and quantitative analysis of furosemide and 4-chloro-5-sulfamoylanthranilic adid (CSA) by high pressure liquid chromatographyM L MacDougall, D W Shoeman, D L AzarnoffArchives Internationales De Pharmacodynamie Et De Therapie|July 1, 1978
Hepatic peroxisome proliferation: induction by BR-931, a hypolipidemic analog of WY-14,643J K Reddy, D L Azarnoff, C R SirtoriCancer Treatment Reports|January 1, 1978
Separation and identification of impurities in parenteral methotrexate dosage formsC E Hignite, D D Shen, D L AzarnoffBiochemical Pharmacology|August 15, 1984
Peroxisome-associated enzymes and serum lipids in tumour-bearing rats treated with peroxisome-proliferating agentsD E Moody, J K Reddy, D L AzarnoffPageof 12